Modified breast cancer model for preclinical immunotherapy studies.
about
Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer.Murine breast cancer mastectomy model that predicts patient outcomes for drug development.ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer.
P2860
Modified breast cancer model for preclinical immunotherapy studies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Modified breast cancer model for preclinical immunotherapy studies.
@en
type
label
Modified breast cancer model for preclinical immunotherapy studies.
@en
prefLabel
Modified breast cancer model for preclinical immunotherapy studies.
@en
P2093
P2860
P1476
Modified breast cancer model for preclinical immunotherapy studies
@en
P2093
Giao Q Phan
Harry D Bear
Krista P Terracina
Sarah Spiegel
Stephanie C DeMasi
P2860
P304
P356
10.1016/J.JSS.2016.06.003
P577
2016-06-08T00:00:00Z